[1]
Halford GM, Lordkipanidzé M, Watson SP. 50th anniversary of the discovery of ibuprofen: an interview with Dr Stewart Adams. Platelets. 2012:23(6):415-22. doi: 10.3109/09537104.2011.632032. Epub 2011 Nov 18
[PubMed PMID: 22098129]
Level 3 (low-level) evidence
[2]
González-Barnadas A, Camps-Font O, Martín-Fatás P, Figueiredo R, Gay-Escoda C, Valmaseda-Castellón E. Efficacy and safety of selective COX-2 inhibitors for pain management after third molar removal: a meta-analysis of randomized clinical trials. Clinical oral investigations. 2020 Jan:24(1):79-96. doi: 10.1007/s00784-019-02910-3. Epub 2019 Apr 23
[PubMed PMID: 31016540]
Level 1 (high-level) evidence
[3]
Upadhyay A, Amanullah A, Joshi V, Dhiman R, Prajapati VK, Poluri KM, Mishra A. Ibuprofen-based advanced therapeutics: breaking the inflammatory link in cancer, neurodegeneration, and diseases. Drug metabolism reviews. 2021 Feb:53(1):100-121. doi: 10.1080/03602532.2021.1903488. Epub 2021 Apr 5
[PubMed PMID: 33820460]
[4]
Terada N, Shimizu Y, Kamba T, Inoue T, Maeno A, Kobayashi T, Nakamura E, Kamoto T, Kanaji T, Maruyama T, Mikami Y, Toda Y, Matsuoka T, Okuno Y, Tsujimoto G, Narumiya S, Ogawa O. Identification of EP4 as a potential target for the treatment of castration-resistant prostate cancer using a novel xenograft model. Cancer research. 2010 Feb 15:70(4):1606-15. doi: 10.1158/0008-5472.CAN-09-2984. Epub 2010 Feb 9
[PubMed PMID: 20145136]
[5]
Gordo AC, Walker C, Armada B, Zhou D. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial. The Journal of international medical research. 2017 Feb:45(1):59-74. doi: 10.1177/0300060516673707. Epub 2017 Jan 12
[PubMed PMID: 28222627]
Level 1 (high-level) evidence
[6]
Ferguson JM. Pharmacotherapy for patent ductus arteriosus closure. Congenital heart disease. 2019 Jan:14(1):52-56. doi: 10.1111/chd.12715. Epub 2018 Dec 11
[PubMed PMID: 30536827]
[7]
Hamrick SEG, Sallmon H, Rose AT, Porras D, Shelton EL, Reese J, Hansmann G. Patent Ductus Arteriosus of the Preterm Infant. Pediatrics. 2020 Nov:146(5):. doi: 10.1542/peds.2020-1209. Epub
[PubMed PMID: 33093140]
[8]
Cajaraville JP. Ibuprofen Arginate for Rapid-Onset Pain Relief in Daily Practice: A Review of Its Use in Different Pain Conditions. Journal of pain research. 2021:14():117-126. doi: 10.2147/JPR.S280571. Epub 2021 Jan 25
[PubMed PMID: 33531831]
[9]
Narayan K, Cooper S, Morphet J, Innes K. Effectiveness of paracetamol versus ibuprofen administration in febrile children: A systematic literature review. Journal of paediatrics and child health. 2017 Aug:53(8):800-807. doi: 10.1111/jpc.13507. Epub 2017 Apr 24
[PubMed PMID: 28437025]
Level 1 (high-level) evidence
[10]
Luo S, Ran M, Luo Q, Shu M, Guo Q, Zhu Y, Xie X, Zhang C, Wan C. Alternating Acetaminophen and Ibuprofen versus Monotherapies in Improvements of Distress and Reducing Refractory Fever in Febrile Children: A Randomized Controlled Trial. Paediatric drugs. 2017 Oct:19(5):479-486. doi: 10.1007/s40272-017-0237-1. Epub
[PubMed PMID: 28523589]
Level 1 (high-level) evidence
[11]
Qaseem A, McLean RM, O'Gurek D, Batur P, Lin K, Kansagara DL, Clinical Guidelines Committee of the American College of Physicians, Commission on Health of the Public and Science of the American Academy of Family Physicians, Cooney TG, Forciea MA, Crandall CJ, Fitterman N, Hicks LA, Horwitch C, Maroto M, McLean RM, Mustafa RA, Tufte J, Vijan S, Williams JW Jr. Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of Family Physicians. Annals of internal medicine. 2020 Nov 3:173(9):739-748. doi: 10.7326/M19-3602. Epub 2020 Aug 18
[PubMed PMID: 32805126]
[12]
Xie R, Li J, Jing Y, Tian J, Li H, Cai Y, Wang Y, Chen W, Xu F. Efficacy and safety of simple analgesics for acute treatment of episodic tension-type headache in adults: a network meta-analysis. Annals of medicine. 2024 Dec:56(1):2357235. doi: 10.1080/07853890.2024.2357235. Epub 2024 May 30
[PubMed PMID: 38813682]
Level 1 (high-level) evidence
[13]
Durain D. Primary dysmenorrhea: assessment and management update. Journal of midwifery & women's health. 2004 Nov-Dec:49(6):520-8
[PubMed PMID: 15544981]
[14]
Jaafarpour M, Hatefi M, Khani A, Khajavikhan J. Comparative effect of cinnamon and Ibuprofen for treatment of primary dysmenorrhea: a randomized double-blind clinical trial. Journal of clinical and diagnostic research : JCDR. 2015 Apr:9(4):QC04-7. doi: 10.7860/JCDR/2015/12084.5783. Epub 2015 Apr 1
[PubMed PMID: 26023601]
Level 2 (mid-level) evidence
[15]
Chen J, Jiang QD, Wu YM, Liu P, Yao JH, Lu Q, Zhang H, Duan JA. Potential of Essential Oils as Penetration Enhancers for Transdermal Administration of Ibuprofen to Treat Dysmenorrhoea. Molecules (Basel, Switzerland). 2015 Oct 7:20(10):18219-36. doi: 10.3390/molecules201018219. Epub 2015 Oct 7
[PubMed PMID: 26457698]
[16]
Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, Becker ML, Cron RQ, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Kimura Y, Lee T, Murphy K, Nigrovic PA, Ombrello MJ, Rabinovich CE, Tesher M, Twilt M, Klein-Gitelman M, Barbar-Smiley F, Cooper AM, Edelheit B, Gillispie-Taylor M, Hays K, Mannion ML, Peterson R, Flanagan E, Saad N, Sullivan N, Szymanski AM, Trachtman R, Turgunbaev M, Veiga K, Turner AS, Reston JT. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Arthritis & rheumatology (Hoboken, N.J.). 2022 Apr:74(4):553-569. doi: 10.1002/art.42037. Epub 2022 Mar 1
[PubMed PMID: 35233993]
[17]
Schweitz MC, Nashel DJ, Alepa FP. Ibuprofen in the treatment of acute gouty arthritis. JAMA. 1978 Jan 2:239(1):34-5
[PubMed PMID: 579229]
[18]
Coburn BW, Mikuls TR. Treatment Options for Acute Gout. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2016 Jan:33(1):35-40
[PubMed PMID: 30766136]
[19]
Schwier N, Tran N. Non-Steroidal Anti-Inflammatory Drugs and Aspirin Therapy for the Treatment of Acute and Recurrent Idiopathic Pericarditis. Pharmaceuticals (Basel, Switzerland). 2016 Mar 23:9(2):. doi: 10.3390/ph9020017. Epub 2016 Mar 23
[PubMed PMID: 27023565]
[20]
Bayes-Genis A, Adler Y, de Luna AB, Imazio M. Colchicine in Pericarditis. European heart journal. 2017 Jun 7:38(22):1706-1709. doi: 10.1093/eurheartj/ehx246. Epub
[PubMed PMID: 30052886]
[21]
Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH, Grizzard JD, Montecucco F, Berrocal DH, Brucato A, Imazio M, Abbate A. Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2020 Jan 7:75(1):76-92. doi: 10.1016/j.jacc.2019.11.021. Epub
[PubMed PMID: 31918837]
[22]
Ekinci M, Ciftci B, Celik EC, Köse EA, Karakaya MA, Ozdenkaya Y. A Randomized, Placebo-Controlled, Double-Blind Study that Evaluates Efficacy of Intravenous Ibuprofen and Acetaminophen for Postoperative Pain Treatment Following Laparoscopic Cholecystectomy Surgery. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2020 Apr:24(4):780-785. doi: 10.1007/s11605-019-04220-1. Epub 2019 Apr 22
[PubMed PMID: 31012040]
Level 1 (high-level) evidence
[23]
Bibbins-Domingo K, U.S. Preventive Services Task Force. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine. 2016 Jun 21:164(12):836-45. doi: 10.7326/M16-0577. Epub 2016 Apr 12
[PubMed PMID: 27064677]
[24]
Hiľovská L, Jendželovský R, Fedoročko P. Potency of non-steroidal anti-inflammatory drugs in chemotherapy. Molecular and clinical oncology. 2015 Jan:3(1):3-12
[PubMed PMID: 25469262]
[25]
Harris RE, Beebe-Donk J, Doss H, Burr Doss D. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncology reports. 2005 Apr:13(4):559-83
[PubMed PMID: 15756426]
[26]
Cuzick J, Otto F, Baron JA, Brown PH, Burn J, Greenwald P, Jankowski J, La Vecchia C, Meyskens F, Senn HJ, Thun M. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. The Lancet. Oncology. 2009 May:10(5):501-7. doi: 10.1016/S1470-2045(09)70035-X. Epub
[PubMed PMID: 19410194]
Level 3 (low-level) evidence
[27]
Wawro ME, Sobierajska K, Ciszewski WM, Niewiarowska J. Nonsteroidal Anti-Inflammatory Drugs Prevent Vincristine-Dependent Cancer-Associated Fibroblasts Formation. International journal of molecular sciences. 2019 Apr 20:20(8):. doi: 10.3390/ijms20081941. Epub 2019 Apr 20
[PubMed PMID: 31010006]
[28]
Akgul O, Di Cesare Mannelli L, Vullo D, Angeli A, Ghelardini C, Bartolucci G, Alfawaz Altamimi AS, Scozzafava A, Supuran CT, Carta F. Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis. Journal of medicinal chemistry. 2018 Jun 14:61(11):4961-4977. doi: 10.1021/acs.jmedchem.8b00420. Epub 2018 May 21
[PubMed PMID: 29746127]
[29]
Harizi H, Corcuff JB, Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends in molecular medicine. 2008 Oct:14(10):461-9. doi: 10.1016/j.molmed.2008.08.005. Epub 2008 Sep 4
[PubMed PMID: 18774339]
[30]
Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. The Journal of pharmacology and experimental therapeutics. 2005 Oct:315(1):1-7
[PubMed PMID: 15879007]
[31]
BenSalem S, Salem A, Boukhris O, Taheri M, Ammar A, Souissi N, Glenn JM, Trabelsi K, Chtourou H. Acute ingestion of acetaminophen improves cognitive and repeated high intensity short-term maximal performance in well-trained female athletes: a randomized placebo-controlled trial. European journal of applied physiology. 2024 Jun 28:():. doi: 10.1007/s00421-024-05534-y. Epub 2024 Jun 28
[PubMed PMID: 38951182]
Level 1 (high-level) evidence
[32]
Zhang X, Morham SG, Langenbach R, Young DA. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. The Journal of experimental medicine. 1999 Aug 16:190(4):451-59
[PubMed PMID: 10449516]
[33]
Wasilewicz MP, Kołodziej B, Bojułko T, Kaczmarczyk M, Sulzyc-Bielicka V, Bielicki D, Ciepiela K. Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. International journal of colorectal disease. 2010 Sep:25(9):1079-85. doi: 10.1007/s00384-010-0980-z. Epub 2010 Jun 12
[PubMed PMID: 20549218]
[34]
Metzger K, Angres G, Maier H, Lehmann WD. Lipoxygenase products in human saliva: patients with oral cancer compared to controls. Free radical biology & medicine. 1995 Feb:18(2):185-94
[PubMed PMID: 7744301]
[35]
Chen Y, Hu Y, Zhang H, Peng C, Li S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nature genetics. 2009 Jul:41(7):783-92. doi: 10.1038/ng.389. Epub 2009 Jun 7
[PubMed PMID: 19503090]
[36]
Tang DG, Bhatia B, Tang S, Schneider-Broussard R. 15-lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins & other lipid mediators. 2007 Jan:82(1-4):135-46
[PubMed PMID: 17164141]
[37]
Mazaleuskaya LL, Theken KN, Gong L, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: ibuprofen pathways. Pharmacogenetics and genomics. 2015 Feb:25(2):96-106. doi: 10.1097/FPC.0000000000000113. Epub
[PubMed PMID: 25502615]
[38]
Bagher AM. Association of CYP2C9∗3 and CYP2C8∗3 Non-Functional Alleles with Ibuprofen-Induced Upper Gastrointestinal Toxicity in a Saudi Patient. Case reports in medicine. 2023:2023():6623269. doi: 10.1155/2023/6623269. Epub 2023 Jul 21
[PubMed PMID: 37520310]
Level 3 (low-level) evidence
[39]
Su J, Zhang C, Su Y, Huang C, Zhao J, Yang H, Xu Z, Li J, Yang X. Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Formulations of 0.2-g Ibuprofen Granules. Clinical pharmacology in drug development. 2023 Jun:12(6):588-593. doi: 10.1002/cpdd.1211. Epub 2022 Dec 28
[PubMed PMID: 36575962]
[40]
Garcia J, Garg A, Song Y, Fotios A, Andersen C, Garg S. Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion. PloS one. 2018:13(1):e0190577. doi: 10.1371/journal.pone.0190577. Epub 2018 Jan 3
[PubMed PMID: 29298359]
[41]
Liu SC, Qiao XF, Tang QX, Li XG, Yang JH, Wang TQ, Xiao YJ, Qiao JM. A retrospective study of acupuncture as an adjunctive therapy to topical ibuprofen for chronic knee pain due to osteoarthritis. Medicine. 2019 Apr:98(17):e15308. doi: 10.1097/MD.0000000000015308. Epub
[PubMed PMID: 31027096]
Level 2 (mid-level) evidence
[42]
Bushra R, Aslam N. An overview of clinical pharmacology of Ibuprofen. Oman medical journal. 2010 Jul:25(3):155-1661. doi: 10.5001/omj.2010.49. Epub
[PubMed PMID: 22043330]
Level 3 (low-level) evidence
[43]
Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, Navarro V. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology (Baltimore, Md.). 2023 Mar 1:77(3):1036-1065. doi: 10.1002/hep.32689. Epub 2023 Feb 17
[PubMed PMID: 35899384]
[44]
Baker M, Perazella MA. NSAIDs in CKD: Are They Safe? American journal of kidney diseases : the official journal of the National Kidney Foundation. 2020 Oct:76(4):546-557. doi: 10.1053/j.ajkd.2020.03.023. Epub 2020 May 30
[PubMed PMID: 32479922]
[45]
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney international. 2024 Apr:105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018. Epub
[PubMed PMID: 38490803]
Level 1 (high-level) evidence
[46]
D'Ambrosio V, Vena F, Scopelliti A, D'Aniello D, Savastano G, Brunelli R, Giancotti A. Use of non-steroidal anti-inflammatory drugs in pregnancy and oligohydramnios: a review. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2023 Dec:36(2):2253956. doi: 10.1080/14767058.2023.2253956. Epub 2023 Sep 27
[PubMed PMID: 38092425]
[48]
Bachar G, Alter A, Justman N, Buchnik Fater G, Farago N, Ben-David C, Abu-Rass H, Siegler Y, Hajaj A, Landau-Levin M, Zipori Y, Khatib N, Weiner Z, Vitner D. Fixed-time interval vs on-demand oral analgesia after vaginal delivery: a randomized controlled trial. American journal of obstetrics & gynecology MFM. 2024 May:6(5):101372. doi: 10.1016/j.ajogmf.2024.101372. Epub 2024 Apr 5
[PubMed PMID: 38583715]
Level 1 (high-level) evidence
[49]
Shamsaee E, Huws A, Gill A, McWilliam SJ, Hawcutt DB. Ibuprofen efficacy, tolerability and safety in obese children: a systematic review. Archives of disease in childhood. 2023 Jan:108(1):67-71. doi: 10.1136/archdischild-2022-324652. Epub 2022 Nov 16
[PubMed PMID: 36385006]
Level 1 (high-level) evidence
[50]
de Martino M, Chiarugi A, Boner A, Montini G, De' Angelis GL. Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal. Drugs. 2017 Aug:77(12):1295-1311. doi: 10.1007/s40265-017-0751-z. Epub
[PubMed PMID: 28597358]
[51]
Gupta S, Subhedar NV, Bell JL, Field D, Bowler U, Hutchison E, Johnson S, Kelsall W, Pepperell J, Roberts T, Sinha S, Stanbury K, Wyllie J, Hardy P, Juszczak E, Baby-OSCAR Collaborative Group. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen. The New England journal of medicine. 2024 Jan 25:390(4):314-325. doi: 10.1056/NEJMoa2305582. Epub
[PubMed PMID: 38265644]
[52]
By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023 Jul:71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4
[PubMed PMID: 37139824]
[53]
Houlind MB, Petersen KK, Palm H, Jørgensen LM, Aakjær M, Christrup LL, Petersen J, Andersen O, Treldal C. Creatinine-Based Renal Function Estimates and Dosage of Postoperative Pain Management for Elderly Acute Hip Fracture Patients. Pharmaceuticals (Basel, Switzerland). 2018 Sep 18:11(3):. doi: 10.3390/ph11030088. Epub 2018 Sep 18
[PubMed PMID: 30231578]
[54]
Rafaniello C, Ferrajolo C, Sullo MG, Sessa M, Sportiello L, Balzano A, Manguso F, Aiezza ML, Rossi F, Scarpignato C, Capuano A. Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system. Pharmacological research. 2016 Feb:104():108-14. doi: 10.1016/j.phrs.2015.12.026. Epub 2015 Dec 29
[PubMed PMID: 26739516]
[55]
Mărginean MO, Meliț LE, Mocanu S, Săsăran V. Ibuprofen, a Potential Cause of Acute Hemorrhagic Gastritis in Children - A Case Report. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures). 2018 Oct:4(4):143-146. doi: 10.2478/jccm-2018-0022. Epub 2018 Oct 1
[PubMed PMID: 30574567]
Level 3 (low-level) evidence
[56]
Balestracci A, Ezquer M, Elmo ME, Molini A, Thorel C, Torrents M, Toledo I. Ibuprofen-associated acute kidney injury in dehydrated children with acute gastroenteritis. Pediatric nephrology (Berlin, Germany). 2015 Oct:30(10):1873-8. doi: 10.1007/s00467-015-3105-7. Epub 2015 Apr 21
[PubMed PMID: 25895445]
[57]
Lipman GS, Shea K, Christensen M, Phillips C, Burns P, Higbee R, Koskenoja V, Eifling K, Krabak BJ. Ibuprofen versus placebo effect on acute kidney injury in ultramarathons: a randomised controlled trial. Emergency medicine journal : EMJ. 2017 Oct:34(10):637-642. doi: 10.1136/emermed-2016-206353. Epub 2017 Jul 5
[PubMed PMID: 28679502]
Level 1 (high-level) evidence
[59]
Watanabe T, Abe M, Tada F, Aritomo K, Ochi H, Koizumi Y, Tokumoto Y, Hirooka M, Kumagi T, Ikeda Y, Matsuura B, Hiasa Y. Drug-induced liver injury with serious multiform exudative erythema following the use of an over-the-counter medication containing ibuprofen. Internal medicine (Tokyo, Japan). 2015:54(4):395-9. doi: 10.2169/internalmedicine.54.3204. Epub
[PubMed PMID: 25748955]
[60]
Johnson AG, Simons LA, Simons J, Friedlander Y, McCallum J. Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. British journal of clinical pharmacology. 1993 May:35(5):455-9
[PubMed PMID: 8512757]
Level 2 (mid-level) evidence
[61]
Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC cardiovascular disorders. 2012 Oct 24:12():93. doi: 10.1186/1471-2261-12-93. Epub 2012 Oct 24
[PubMed PMID: 23092442]
Level 2 (mid-level) evidence
[62]
Thibaut C, Hazard A, Huon C, Desfrere L. Effect of ibuprofen on bilirubin-albumin binding during the treatment of patent ductus arteriosus in preterm infant. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2011 Nov:24 Suppl 3():7-9. doi: 10.3109/14767058.2011.609326. Epub 2011 Sep 23
[PubMed PMID: 21815876]
[63]
Weng SE, Hsu WT, Hsiao FY, Lee CM. Non-steroidal anti-inflammatory drugs, renin-angiotensin system blockade or diuretics and risk of acute kidney injury: A case-crossover study. Archives of gerontology and geriatrics. 2024 Aug:123():105394. doi: 10.1016/j.archger.2024.105394. Epub 2024 Mar 26
[PubMed PMID: 38537386]
Level 3 (low-level) evidence
[64]
Hassan S, Khalid F, Alirhayim Z, Amer S. Lithium toxicity in the setting of nonsteroidal anti-inflammatory medications. Case reports in nephrology. 2013:2013():839796. doi: 10.1155/2013/839796. Epub 2013 Apr 3
[PubMed PMID: 24558630]
Level 3 (low-level) evidence
[65]
Gomez Lumbreras A, Reese TJ, Del Fiol G, Tan MS, Butler JM, Hurwitz JT, Brown M, Kawamoto K, Thiess H, Wright M, Malone DC. Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction. JMIR formative research. 2022 Oct 19:6(10):e40018. doi: 10.2196/40018. Epub 2022 Oct 19
[PubMed PMID: 36260377]
[66]
Walsh P, Rothenberg SJ, Bang H. Safety of ibuprofen in infants younger than six months: A retrospective cohort study. PloS one. 2018:13(6):e0199493. doi: 10.1371/journal.pone.0199493. Epub 2018 Jun 28
[PubMed PMID: 29953460]
Level 2 (mid-level) evidence
[67]
Cavkaytar O, du Toit G, Caimmi D. Characteristics of NSAID-induced hypersensitivity reactions in childhood. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2019 Feb:30(1):25-35. doi: 10.1111/pai.12980. Epub 2018 Nov 5
[PubMed PMID: 30194799]
[68]
Kulik A, Bykov K, Choudhry NK, Bateman BT. Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning. Pharmacoepidemiology and drug safety. 2015 Jun:24(6):647-53. doi: 10.1002/pds.3788. Epub 2015 Apr 22
[PubMed PMID: 25907164]
[69]
Marchlewicz A, Guzik U, Hupert-Kocurek K, Nowak A, Wilczyńska S, Wojcieszyńska D. Toxicity and biodegradation of ibuprofen by Bacillus thuringiensis B1(2015b). Environmental science and pollution research international. 2017 Mar:24(8):7572-7584. doi: 10.1007/s11356-017-8372-3. Epub 2017 Jan 23
[PubMed PMID: 28116629]
[70]
Rubasinghege G, Gurung R, Rijal H, Maldonado-Torres S, Chan A, Acharya S, Rogelj S, Piyasena M. Abiotic degradation and environmental toxicity of ibuprofen: Roles of mineral particles and solar radiation. Water research. 2018 Mar 15:131():22-32. doi: 10.1016/j.watres.2017.12.016. Epub 2017 Dec 11
[PubMed PMID: 29258002]
[71]
Norman H, Elfineh M, Beijer E, Casswall T, Németh A. [Also ibuprofen, not just paracetamol, can cause serious liver damage in children. NSAIDs should be used with caution in children, as shown in case with fatal outcome]. Lakartidningen. 2014 Oct 1-7:111(40):1709-11
[PubMed PMID: 25759881]
Level 3 (low-level) evidence
[73]
Solomon DH, Shao M, Wolski K, Nissen S, Husni ME, Paynter N. Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.). 2019 Aug:71(8):1225-1231. doi: 10.1002/art.40870. Epub 2019 Jun 12
[PubMed PMID: 30801994]
Level 1 (high-level) evidence
[74]
Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug metabolism reviews. 2012 Feb:44(1):88-106. doi: 10.3109/03602532.2011.602688. Epub 2012 Jan 10
[PubMed PMID: 22229890]
[75]
Pollack BE, Barbaro RP, Selewski DT, Carlton EF. Lactic acidosis and multisystem organ failure following ibuprofen overdose requiring haemodialysis. BMJ case reports. 2022 Feb 7:15(2):. doi: 10.1136/bcr-2021-244281. Epub 2022 Feb 7
[PubMed PMID: 35131772]
Level 3 (low-level) evidence
[76]
Tao X, Thijssen S, Kotanko P, Ho CH, Henrie M, Stroup E, Handelman G. Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Scientific reports. 2016 Mar 22:6():23389. doi: 10.1038/srep23389. Epub 2016 Mar 22
[PubMed PMID: 27001248]